INHIBRX BIOSCIENCES, INC. Shares Outstanding (Cover Page)
INHIBRX BIOSCIENCES, INC. (INBX) had Shares Outstanding (Cover Page) of 14.72 million shares as of 2026-08-07, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-13
- 2026-08-07: Entity Common Stock, Shares Outstanding 14.72M shares.
- 2026-05-08: Entity Common Stock, Shares Outstanding 14.67M shares.
- 2026-03-11: Entity Common Stock, Shares Outstanding 14.61M shares.
- 2025-11-07: Entity Common Stock, Shares Outstanding 14.54M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-07 | 14.72M shares 10-Q · filed 2026-08-13 |
| 2026-05-08 | 14.67M shares 10-Q · filed 2026-05-14 |
| 2026-03-11 | 14.61M shares 10-K · filed 2026-03-19 |
| 2025-11-07 | 14.54M shares 10-Q · filed 2025-11-14 |
| 2025-08-08 | 14.49M shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 14.48M shares 10-Q · filed 2025-05-14 |
| 2025-02-28 | 14.48M shares 10-K · filed 2025-03-17 |
| 2024-11-08 | 14.48M shares 10-Q · filed 2024-11-14 |
| 2024-08-09 | 14.48M shares 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |